| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 59.380 | 38.849 | 37.916 | 102.017 | 141.613 | 226.553 | 174.627 | 124.379 | 157.424 | 178.387 |
| Total Income - EUR | 59.883 | 39.175 | 37.979 | 102.023 | 142.093 | 226.562 | 174.670 | 128.005 | 157.453 | 187.059 |
| Total Expenses - EUR | 55.809 | 36.580 | 36.850 | 93.161 | 131.022 | 200.304 | 154.946 | 100.519 | 142.626 | 165.112 |
| Gross Profit/Loss - EUR | 4.074 | 2.595 | 1.129 | 8.862 | 11.071 | 26.259 | 19.725 | 27.486 | 14.827 | 21.947 |
| Net Profit/Loss - EUR | 2.282 | 1.816 | 484 | 7.842 | 9.651 | 24.169 | 18.187 | 26.399 | 13.521 | 17.320 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Marlyd Medical Devices Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.389 | 17.905 | 13.196 | 8.628 | 4.477 | 186 | 505 | 835 | 0 | 8.582 |
| Current Assets | 26.438 | 22.177 | 23.801 | 37.463 | 43.632 | 93.855 | 150.823 | 190.194 | 215.685 | 173.162 |
| Inventories | 7.490 | 17.468 | 18.267 | 18.091 | 6.333 | 1.492 | 2.733 | 2.816 | 385 | 1.017 |
| Receivables | 2.408 | 2.350 | 3.289 | 16.930 | 32.545 | 77.242 | 134.549 | 174.276 | 190.747 | 166.919 |
| Cash | 16.540 | 2.358 | 2.245 | 2.443 | 4.754 | 15.121 | 13.540 | 13.103 | 24.553 | 5.226 |
| Shareholders Funds | 12.271 | 13.961 | 14.209 | 21.790 | 25.314 | 49.003 | 66.104 | 92.708 | 105.948 | 97.547 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 39.873 | 30.393 | 26.988 | 28.820 | 27.226 | 45.038 | 85.224 | 98.321 | 109.737 | 84.197 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Marlyd Medical Devices Srl